Geographic Variation in Prescription Patterns of Parkinson's Disease Medications

2021 ◽  
Author(s):  
Michiko K. Bruno ◽  
Gina Watanabe ◽  
Kyle Ishikawa ◽  
John J. Chen ◽  
Fay Gao ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Geographic Variation ◽  
Prescription Patterns

Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease

2011 ◽  
Vol 26 (9) ◽  
pp. 1663-1669 ◽  
Author(s):  
Meng-Ting Wang ◽  
Pei-Wen Lian ◽  
Chin-Bin Yeh ◽  
Che-Hung Yen ◽  
Kao-Hsing Ma ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Prescription Patterns

scholarly journals Geographic variation in neurologist density and neurologic care in the United States

Neurology ◽  
2020 ◽  
pp. 10.1212/WNL.0000000000011276
Author(s):  
Chun Chieh Lin ◽  
Brian C. Callaghan ◽  
James F. Burke ◽  
Lesli E. Skolarus ◽  
Chloe E. Hill ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Geographic Variation ◽  
The United States ◽  
Primary Diagnosis ◽  
Absolute Difference ◽  
Hospital Referral Region ◽  
Hospital Referral ◽  
The Difference

Objective:To describe geographic variation in neurologist density, neurologic conditions, and neurologist involvement in neurologic care.Methods:We used 20% 2015 Medicare data to summarize variation by Hospital Referral Region (HRR). Neurologic care was defined as office-based evaluation/management visits with a primary diagnosis of a neurologic condition.Results:Mean density of neurologists varied nearly 4-fold from the lowest to the highest density quintile (9.7 [95%CI: 9.2-10.2] vs. 43.1 [95%CI: 37.6-48.5] per 100,000 Medicare beneficiaries). The mean prevalence of patients with neurologic conditions did not substantially differ across neurologist density quintile regions (293 vs. 311 per 1,000 beneficiaries in the lowest vs. highest quintiles, respectively). Of patients with a neurologic condition, 23.5% were seen by a neurologist, ranging from 20.6% in the lowest quintile regions to 27.0% in the highest quintile regions (6.4% absolute difference). Most of the difference was comprised of dementia, pain, and stroke conditions seen by neurologists. In contrast, very little of the difference was comprised of Parkinson’s disease and multiple sclerosis both of which had a very high proportion (>80%) of neurologist involvement even in the lowest quintile regions.Conclusions:The supply of neurologists varies substantially by region, but the prevalence of neurologic conditions does not. As neurologist supply increases, access to neurologist care for certain neurologic conditions (dementia, pain, and stroke) increases much more than for others (Parkinson’s disease and multiple sclerosis). These data provide insight for policy makers when considering strategies in matching the demand for neurologic care with the appropriate supply of neurologists.

scholarly journals Geographic Variation of Parkinson's Disease and Stroke in the Southeastern United States

2006 ◽  
Vol 163 (suppl_11) ◽  
pp. S178-S178
Author(s):  
K Rodgers ◽  
K Bergmann ◽  
V Salak ◽  
L Mohr ◽  
D Lackland
Keyword(s):  
United States ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Geographic Variation ◽  
Southeastern United States

Evaluation of Efferent Auditory System and Hearing Quality in Parkinson's Disease: Is the Difficulty in Speech Understanding in Complex Listening Conditions Related to Neural Degeneration or Aging?

2020 ◽  
pp. 1-9
Author(s):  
Nuriye Yıldırım Gökay ◽  
Bülent Gündüz ◽  
Fatih Söke ◽  
Recep Karamert
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Auditory System ◽  
Otoacoustic Emissions ◽  
Pure Tone ◽  
Pure Tone Audiometry ◽  
Auditory Pathway ◽  
Normal Hearing ◽  
System Function ◽  
Distortion Product

Purpose The effects of neurological diseases on the auditory system have been a notable issue for investigators because the auditory pathway is closely associated with neural systems. The purposes of this study are to evaluate the efferent auditory system function and hearing quality in Parkinson's disease (PD) and to compare the findings with age-matched individuals without PD to present a perspective on aging. Method The study included 35 individuals with PD (mean age of 48.50 ± 8.00 years) and 35 normal-hearing peers (mean age of 49 ± 10 years). The following tests were administered for all participants: the first section of the Speech, Spatial and Qualities of Hearing Scale; pure-tone audiometry, speech audiometry, tympanometry, and acoustic reflexes; and distortion product otoacoustic emissions (DPOAEs) and contralateral suppression of DPOAEs. SPSS Version 25 was used for statistical analyses, and values of p < .05 were considered statistically significant. Results There were no statistically significant differences in the pure-tone audiometry thresholds and DPOAE responses between the individuals with PD and their normal-hearing peers ( p = .732). However, statistically significant differences were found between the groups in suppression levels of DPOAEs and hearing quality ( p < .05). In addition, a statistically significant and positive correlation was found between the amount of suppression at some frequencies and the Speech, Spatial and Qualities of Hearing Scale scores. Conclusions This study indicates that medial olivocochlear efferent system function and the hearing quality of individuals with PD were affected adversely due to the results of PD pathophysiology on the hearing system. For optimal intervention and follow-up, tasks related to hearing quality in daily life can also be added to therapies for PD.

Accessible Internet Training for People With Aphasia and Parkinson's Disease

2004 ◽  
Vol 9 (2) ◽  
pp. 10-13
Author(s):  
Linda Worrall ◽  
Jennifer Egan ◽  
Dorothea Oxenham ◽  
Felicity Stewart
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease

Voice Treatment for Individuals With Parkinson's Disease

2007 ◽  
Vol 12 (1) ◽  
pp. 2-11
Author(s):  
Lorraine Ramig ◽  
Cynthia Fox
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Voice Treatment
Sign in / Sign up

Export Citation Format

Share Document